HashiCorp Valuation
Is HCP * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of HCP * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: HCP * (MX$565) is trading above our estimate of fair value (MX$385.29)
Significantly Below Fair Value: HCP * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for HCP *?
Other financial metrics that can be useful for relative valuation.
What is HCP *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$6.77b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 9x |
Enterprise Value/EBITDA | -22.4x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does HCP *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 5.5x | ||
U Unity Software | 2.9x | 3.1% | US$6.4b |
SMAR Smartsheet | 6.1x | 14.3% | US$6.1b |
COUP Coupa Software | 7.5x | 16.0% | US$6.1b |
TOI Topicus.com | 5.6x | 20.0% | CA$9.7b |
HCP * HashiCorp | 11.2x | 13.5% | Mex$6.8b |
Price-To-Sales vs Peers: HCP * is expensive based on its Price-To-Sales Ratio (11.2x) compared to the peer average (4.9x).
Price to Earnings Ratio vs Industry
How does HCP *'s PE Ratio compare vs other companies in the Global Software Industry?
Price-To-Sales vs Industry: HCP * is expensive based on its Price-To-Sales Ratio (11.2x) compared to the Global Software industry average (2.9x).
Price to Sales Ratio vs Fair Ratio
What is HCP *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 11.2x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate HCP *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.